Other languages Imagion Biosystems Limited

Equities

IBX

AU000000IBX6

Market Closed - Australian S.E. Other stock markets 01:14:11 2024-07-03 am EDT			5-day change	1st Jan Change
0.082 ^AUD	-2.38%		0.00%	-76.90%

Jul. 02	Imagion Biosystems Limited Announces Change of Registered Office & Principal Place of Business	CI
Feb. 29	Imagion Biosystems Limited Reports Earnings Results for the Full Year Ended December 31, 2023	CI

Other languages

Unlock all the news: Be the first to know and act before the market!

100% Free Registration

Imagion Biosystems Limited Reports Earnings Results for the Full Year Ended December 31, 2023	Feb. 29
Imagion Biosystems CEO Resigns	Jan. 15
Imagion Biosystems Limited Informs Chairman Bob Proulx to Resume Operating Responsibilities as Interim Executive Chair	Jan. 14
Imagion Biosystems Limited Announces Departure of Isaac Bright as CEO	Jan. 14
Imagion Biosystems Validates Safety, Feasibility of Breast Cancer Imaging Agent in Phase One Trial; Shares Rise 7%	Dec. 06
Argenica Therapeutics Appoints Nonexecutive Chair	Nov. 29
Imagion Biosystems Limited Approves Election of Isaac Bright as Director	Nov. 12
Imagion Biosystems Limited Announces Update on Magsense Her2 Program	23-10-01
Imagion Biosystems Limited Reports Earnings Results for the Half Year Ended June 30, 2023	23-08-29
Imagion Biosystems Limited Appoints Robert Proulx as Non-Executive Chairman	23-07-16
Imagion Biosystems Limited Announces Executive Changes	23-07-16
Easing Inflation Boosts Australian Shares	23-06-28
Imagion Biosystems, Siemens Healthineers Expand US Collaboration; Shares Jump 33%	23-06-27
Imagion Biosystems Completes Enrollment for Imaging Agent Trial; Shares Surge 25%	23-06-21
Imagion Biosystems Limited Announces CEO Changes	23-06-18
Imagion Biosystems Limited Announces Resignation of Bob Proulx as CEO	23-04-27
Imagion Biosystems Raises AU$412,903 Via Entitlement Offer; Shares Slip 6%	23-04-19
Imagion Biosystems Sets Timeline for Application Filing of US Phase 2 Study of Breast Cancer Imaging Agent	23-03-27
Imagion Biosystems Limited Provides an Update on Development Plans for Its MagSense HER2 imaging agent	23-03-26
Imagion Biosystems Secures Second Grant Funding for Prostate Cancer Imaging Technology	23-03-01

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Other languages Imagion Biosystems Limited

Equities

IBX

AU000000IBX6

Other languages

Filters